Our Chairs
Congresswoman Diana DeGette
Congresswoman Barbara Lee
-
Remembering Congresswoman Louise Slaughter
The Pro Choice Caucus mourns the loss of Co-chair Louise Slaughter and vows to continue her fearless, decades-long fight to ensure reproductive rights for every woman. -
Seeking Justice for Jane
The Trump administration's efforts to prevent several undocumented teens from obtaining abortions are unacceptable. The caucus is pushing back, demanding answers from administration officials. -
#StopTheBans
The Pro-Choice Caucus strongly opposes H.R. 36, the latest in a long line of Republican efforts to take away women's reproductive rights. We'll continue fighting to block this extreme and dangerous bill. -
Opposing Anti-Choice Provisions
Members of the caucus gathered to condemn the many anti-woman riders in the 2018 appropriations bills -- just one piece of Washington Republicans' dangerous agenda that seeks to roll back women's reproductive health.
Our Mission
The men and women of this caucus are fighting for constitutionally-protected rights for American women that are under siege. Join us!
Latest News
WASHINGTON, D.C. - U.S. Reps. Diana DeGette (D-CO) and Barbara Lee (D-CA), co-chairs of the Pro-Choice Caucus, issued the following statement in the wake of the U.S. House of Representatives move today to – for the first time in more than 40 years – advance an appropriations bill free of the Hyde Amendment:
WASHINGTON, D.C. – Leaders of the Congressional Pro-Choice Caucus hailed the exclusion of the Hyde amendment from President Biden’s first annual budget proposal submitted to Congress today as a significant moment in their fight to expand access to reproductive care.
WASHINGTON, D.C. – The U.S. Supreme Court announced today it will soon hear arguments in Dobbs v. Jackson Women’s Health Organization, a case dealing with the constitutionality of a Mississippi law banning almost all abortions after 15 weeks.
Washington, DC – Pro-Choice Caucus Co-Chairs Diana DeGette (D-CO) and Barbara Lee (D-CA) today applauded the Food and Drug Administration’s (FDA) letter to the American College of Obstetricians and Gynecologists (ACOG) indicating that it will halt enforcement of the medically unnecessary in-person dispensing requirement for mifepristone.